Showcasing Australian biotech at BioKorea 2023


AusBiotech is proud to support Austrade’s BioKorea 2023 delegation to strengthen ties with international markets and highlight investment opportunities in Australia and our national life science capabilities.

Australia’s biotech industry is preparing to highlight the nation’s strengths at Asia’s premier life science conference, BioKorea 2023, this week.

Partnering with the Australian Trade and Investment Commission (Austrade), AusBiotech is backing the Team Australia delegation attending BioKorea from 10-12 May.

The Australian presence will be strong, with industry representation from across five states and several Australian thought leaders providing local insights during BioKorea’s conference sessions, including presentations on regenerative medicines and securing vaccine sovereignty through global collaborations.

Several Australian companies are also expected to pitch at BioKorea’s Invest Fair, which brings together leading investors, venture capitalists, and biotech startups to pitch for investment and partnership.

AusBiotech’s support of BioKorea 2023’s Australian delegation is part of its global strategy to facilitate international opportunities for investment, collaborations and partnerships, with a focus on the markets important to members, including growth markets in Asia.

Australian Ambassador to the Republic of Korea, H.E. Catherine Raper, is flying Team Australia’s flag at BioKorea’s official opening ceremony on 9 May; Global Victoria is hosting an Australian clinical trial seminar on 9 May; and the Australian delegation networking event, co-hosted by Korea Health Industry Development Institute (KHIDI), will take place on 11 May.

AusBiotech is committed to supporting these ongoing opportunities for industry, which are crucial for the growth of the Australian life sciences sector, and ultimately for continuing Australia’s position in the sector globally.

The organiser of BioKorea, KHIDI, has led large Korean delegations to AusBiotech for several years, demonstrating the strong interest Korean companies have in collaborating with Australia's biotech industry. The long-standing MoU with KHIDI will continue to make a solid platform for further international collaborations.

To find out more about BioKorea 2023, click here.